CD8A and nonpapillary renal cell carcinoma: The Study have indicated that the positivity rate for PD-1 expression in CD8 + T cells within the TIME of ccRCC is 21.9%, further emphasizing the significant role of CD8 + T cells in immunotherapy [255].